SEC 13F Intelligence

Boxer Capital, LLC / PMVP

Boxer Capital, LLC’s Pmv Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Pmv Pharmaceuticals Inc (PMVP)? Not currently — the last reported position was 3.16M shares worth $19M in Q3 2023; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$19M
Q3 2023
Shares
3.16M
% of Portfolio
+1.03%
Quarters Held
13
position exited

Position History PMVP

Reported value by quarter
Q3 ’20: $81MQ3 ’20Q4 ’20: $140MQ1 ’21: $75MQ1 ’21Q2 ’21: $77MQ3 ’21: $68MQ3 ’21Q4 ’21: $66MQ1 ’22: $73MQ1 ’22Q2 ’22: $50MQ3 ’22: $38MQ3 ’22Q4 ’22: $28MQ1 ’23: $15,091Q1 ’23Q2 ’23: $19,805Q3 ’23: $19MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20233.16M$19M+1.03%
Q2 20233.16M$19,805+0.92%
Q1 20233.16M$15,091+0.74%
Q4 20223.16M$28M+1.45%
Q3 20223.16M$38M+2.12%
Q2 20223.50M$50M+3.16%
Q1 20223.50M$73M+3.74%
Q4 20212.84M$66M+2.55%
Q3 20212.27M$68M+2.36%
Q2 20212.27M$77M+2.73%
Q1 20212.27M$75M+2.53%
Q4 20202.27M$140M+4.48%
Q3 20202.27M$81M+2.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of PMVP.